Risk factors for increased immune reconstitution in response to Mycobacterium tuberculosis antigens in tuberculosis HIV-infected, antiretroviral-naïve patients

@inproceedings{Silva2017RiskFF,
  title={Risk factors for increased immune reconstitution in response to Mycobacterium tuberculosis antigens in tuberculosis HIV-infected, antiretroviral-na{\"i}ve patients},
  author={Tatiana Pastorello Pereira da Silva and Carmem Beatriz Wagner Giacoia-Gripp and Carolina Arana Stanis Schmaltz and Fl{\'a}via Marinho Sant’Anna and Maria Helena F{\'e}res Saad and Juliana Arruda de Matos and Julio Castro Alves de Lima e Silva and Valeria C Rolla and Mariza Gonçalves Morgado},
  booktitle={BMC infectious diseases},
  year={2017}
}
BackgroundLittle is known regarding the restoration of the specific immune response after combined antiretroviral therapy (cART) and anti-tuberculosis (TB) therapy introduction among TB-HIV patients. In this study, we examined the immune response of TB-HIV patients to Mycobacterium tuberculosis (Mtb) antigens to evaluate the response dynamics to different antigens over time. Moreover, we also evaluated the influence of two different doses of efavirenz and the factors associated with immune… CONTINUE READING
BETA
3
Twitter Mentions

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 32 REFERENCES

48 weeks results

W Manosuthi, S Kiertiburanakul, +4 authors rifampicin et al. Efavirenz 600 mgday versus efavirenz 800 mg receiving
  • AIDS. 2006;20:131–2. • We accept pre-submission inquiries • Our selector tool helps you to find the most relevant journal • We provide round the clock customer support • Convenient online submission • Thorough peer review • Inclusion in PubMed and all major indexing services • Maximum visibility for
  • 2017
VIEW 1 EXCERPT

Tuberculosis (TB) [Internet

WH Organization
  • [cited 2017 Jan 1]. Available from: http://www.who.int/tb/areas-of-work/population-groups/gender/en/
  • 2017
VIEW 1 EXCERPT

Boletim Epidemiológico – Volume 43 – Especial Tuberculose

Ministério da saúde- Brazil
  • Secr. Vigilância em Saúde
  • 2012
VIEW 1 EXCERPT